Infinium Global Research has added a new report on Bovine Respiratory Disease Treatment Market. The report presents analysis of global as well as regional markets of bovine respiratory disease treatment over the period of 2016 to 2024.
Bovine respiratory disease is a commonly occurring respiratory disorder among cattle that may result from a single or a number of factors combined. It is usually caused by a combination of stress and disease causing agents that includes viruses and bacteria. The global market size of bovine respiratory disease treatment market was worth USD XX million and it is projected to reach to USD XX million by 2024 The factors responsible for driving the growth of bovine respiratory disease treatment includes development of novel products and increase in preventive measures against bovine respiratory disease. Furthermore, increase in cattle population across the globe to meet the growing demand of meat consumption. This increase in cattle population is likely to increase chances of bovine respiratory disease among cattle that may facilitate growth in bovine respiratory disease treatment market. However, less awareness about the bovine respiratory disease and its treatment, particularly in developing and underdeveloped regions are some of the restraints that is likely to hinder the growth in the bovine respiratory disease treatment market. Furthermore, advancement of vaccines to treat BRD is likely to boost the bovine respiratory disease market.
Among the regions, North America is expected to dominate the bovine respiratory disease treatment market in 2017, followed by Europe. U.S is responsible for driving the North America region owing to increase awareness about the disease and its treatment, high consumption of beef among its citizen, export of beef and presence of companies responsible for manufacturing vaccines for BRD. Asia Pacific is expected to grow at the highest CAGR during the forecast period owing to rising awareness about BRD disease and its treatment.
Recent Development- In May 2018, Virbac Australia launched a brand new combination treatment designed to tackle bovine respiratory disease. The company launched an antibiotic with a non-steroidal anti-inflammatory drug (NSAID).This new medication is an innovative ‘two-in-one’ solution designed to target infection, inflammation and pain all at once.
Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global bovine respiratory disease treatment market but also make strategic decisions to capture the most lucrative markets in the near future.
The market size is presented in terms of value for the historic year 2016 and estimated for forecast period of 2018-2024.
Get 15% discount for early purchase of global bovine respiratory disease treatment market report by clicking the following link, Use code IGRD15 to request the discount in the given form
https://www.infiniumglobalresearch.com/reports/request-discount/1318
The recent report identified that North America dominated the global bovine respiratory disease treatment market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the bovine respiratory disease treatment market worldwide.
The report segments the global bovine respiratory disease treatment market on the basis of disease type, treatment type and distribution channel.
Global Bovine Respiratory Disease Treatment Market by Disease Type
· Pneumonia
· Upper Respiratory Tract Infections
· Diphtheria
Global Bovine Respiratory Disease Treatment Market by Treatment Type
· Vaccines
· Antibiotics
· Immunomodulators
· Others
Global Bovine Respiratory Disease Treatment Market by Distribution Channel
· Hospitals
· Clinics
· Research Institutions
· Others
Companies Profiled in the Report
· Bayer AG
· Boehringer Ingelheim GmbH
· Bimeda Animal Health
· Elanco
· Vetoquinol
· Merial
· Zoetis Services LLC
· Virbac Group
About Infinium Global Research
Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.
Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.
